-
Something wrong with this record ?
Monitoring of particle sizes distribution during Valsartan precipitation in the presence of nonionic surfactant
D. Trunov, J. Francisco Wilson, M. Ježková, O. Šrom, J. Beranek, O. Dammer, M. Šoóš
Language English Country Netherlands
Document type Journal Article
- MeSH
- Dynamic Light Scattering MeSH
- Pharmaceutical Preparations * MeSH
- Surface-Active Agents MeSH
- Valsartan MeSH
- Particle Size MeSH
- Publication type
- Journal Article MeSH
Particle size is a key parameter when dealing with drug particle formation, delivery or dissolution. The correct measurement of particle size depends on various factors, such as sample preparation or dilution, but also on the choice of method for its characterization. In this work, we study the process of precipitation of poorly water-soluble drug Valsartan from supersaturated solution in the presence of nonionic surfactant Tween 20. Several techniques including dynamic light scattering (DLS) operated in several measuring modes, optical microscope (OM) and static light scattering (SLS) were used to analyze the kinetics of particle formation. As concluded by the results, the increase in turbidity of the solution seriously limits the application of classical DLS to properly measure the particle size and polydispersity. One way to get around this restriction is by dilution, which however results in a decrease in the size of Valsartan particles in the studied population. In contrast, here we present for a first time technique based on modulated 3D cross correlation DLS equipped with the sample goniometer to determine size of submicron particles of the drug in highly turbid solutions. Additionally, a modified OM was used to measure micron-sized particles for samples without any dilution in a continuous mode. Measured particle sizes combined with measured Valsartan concentration allowed us to identify mechanism responsible for the particle formation from supersaturated solutions. The main mechanism, as it is shown in this work, is covering surface of precipitate particles by the amount of used Tween 20.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21018694
- 003
- CZ-PrNML
- 005
- 20230703084313.0
- 007
- ta
- 008
- 210728s2021 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijpharm.2021.120515 $2 doi
- 035 __
- $a (PubMed)33774163
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Trunov, Dan $u Department of Chemical Engineering, University of Chemistry and Technology, Technická 3, 166 28 Prague 6 - Dejvice, Czech Republic. Electronic address: dan.trunov@vscht.cz
- 245 10
- $a Monitoring of particle sizes distribution during Valsartan precipitation in the presence of nonionic surfactant / $c D. Trunov, J. Francisco Wilson, M. Ježková, O. Šrom, J. Beranek, O. Dammer, M. Šoóš
- 520 9_
- $a Particle size is a key parameter when dealing with drug particle formation, delivery or dissolution. The correct measurement of particle size depends on various factors, such as sample preparation or dilution, but also on the choice of method for its characterization. In this work, we study the process of precipitation of poorly water-soluble drug Valsartan from supersaturated solution in the presence of nonionic surfactant Tween 20. Several techniques including dynamic light scattering (DLS) operated in several measuring modes, optical microscope (OM) and static light scattering (SLS) were used to analyze the kinetics of particle formation. As concluded by the results, the increase in turbidity of the solution seriously limits the application of classical DLS to properly measure the particle size and polydispersity. One way to get around this restriction is by dilution, which however results in a decrease in the size of Valsartan particles in the studied population. In contrast, here we present for a first time technique based on modulated 3D cross correlation DLS equipped with the sample goniometer to determine size of submicron particles of the drug in highly turbid solutions. Additionally, a modified OM was used to measure micron-sized particles for samples without any dilution in a continuous mode. Measured particle sizes combined with measured Valsartan concentration allowed us to identify mechanism responsible for the particle formation from supersaturated solutions. The main mechanism, as it is shown in this work, is covering surface of precipitate particles by the amount of used Tween 20.
- 650 _2
- $a dynamický rozptyl světla $7 D000067493
- 650 _2
- $a velikost částic $7 D010316
- 650 12
- $a léčivé přípravky $7 D004364
- 650 _2
- $a povrchově aktivní látky $7 D013501
- 650 _2
- $a valsartan $7 D000068756
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Francisco Wilson, Jose $u Department of Chemical Engineering, University of Chemistry and Technology, Technická 3, 166 28 Prague 6 - Dejvice, Czech Republic
- 700 1_
- $a Ježková, Martina $u Department of Chemical Engineering, University of Chemistry and Technology, Technická 3, 166 28 Prague 6 - Dejvice, Czech Republic
- 700 1_
- $a Šrom, Ondřej $u Department of Chemical Engineering, University of Chemistry and Technology, Technická 3, 166 28 Prague 6 - Dejvice, Czech Republic
- 700 1_
- $a Beranek, Josef $u Zentiva, k.s., U Kabelovny 130, 102 00 Prague 10, Czech Republic
- 700 1_
- $a Dammer, Ondřej $u Zentiva, k.s., U Kabelovny 130, 102 00 Prague 10, Czech Republic $7 xx0303489
- 700 1_
- $a Šoóš, Miroslav $u Department of Chemical Engineering, University of Chemistry and Technology, Technická 3, 166 28 Prague 6 - Dejvice, Czech Republic. Electronic address: miroslav.soos@vscht.cz
- 773 0_
- $w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 600, č. - (2021), s. 120515
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33774163 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20230703084312 $b ABA008
- 999 __
- $a ok $b bmc $g 1689710 $s 1139140
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 600 $c - $d 120515 $e 20210324 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
- LZP __
- $a Pubmed-20210728